431 related articles for article (PubMed ID: 22229578)
1. GRK2 inhibition in heart failure: something old, something new.
Lymperopoulos A; Rengo G; Koch WJ
Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
[TBL] [Abstract][Full Text] [Related]
2. GRK2 as a novel gene therapy target in heart failure.
Rengo G; Lymperopoulos A; Leosco D; Koch WJ
J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
[TBL] [Abstract][Full Text] [Related]
3. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.
Lymperopoulos A; Rengo G; Gao E; Ebert SN; Dorn GW; Koch WJ
J Biol Chem; 2010 May; 285(21):16378-86. PubMed ID: 20351116
[TBL] [Abstract][Full Text] [Related]
4. Gi-biased β2AR signaling links GRK2 upregulation to heart failure.
Zhu W; Petrashevskaya N; Ren S; Zhao A; Chakir K; Gao E; Chuprun JK; Wang Y; Talan M; Dorn GW; Lakatta EG; Koch WJ; Feldman AM; Xiao RP
Circ Res; 2012 Jan; 110(2):265-74. PubMed ID: 22179058
[TBL] [Abstract][Full Text] [Related]
5. The beta-adrenergic receptor kinase in heart failure.
Petrofski JA; Koch WJ
J Mol Cell Cardiol; 2003 Oct; 35(10):1167-74. PubMed ID: 14519424
[TBL] [Abstract][Full Text] [Related]
6. GRK2 as a therapeutic target for heart failure.
Cannavo A; Komici K; Bencivenga L; D'amico ML; Gambino G; Liccardo D; Ferrara N; Rengo G
Expert Opin Ther Targets; 2018 Jan; 22(1):75-83. PubMed ID: 29166798
[TBL] [Abstract][Full Text] [Related]
7. Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.
Rengo G; Lymperopoulos A; Zincarelli C; Femminella G; Liccardo D; Pagano G; de Lucia C; Cannavo A; Gargiulo P; Ferrara N; Perrone Filardi P; Koch W; Leosco D
Br J Pharmacol; 2012 Aug; 166(8):2430-40. PubMed ID: 22519418
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
[TBL] [Abstract][Full Text] [Related]
9. Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy.
Cannavo A; Liccardo D; Koch WJ
Front Physiol; 2013 Sep; 4():264. PubMed ID: 24133451
[TBL] [Abstract][Full Text] [Related]
10. GRK2 in the heart: a GPCR kinase and beyond.
Huang ZM; Gao E; Chuprun JK; Koch WJ
Antioxid Redox Signal; 2014 Nov; 21(14):2032-43. PubMed ID: 24702056
[TBL] [Abstract][Full Text] [Related]
11. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
[TBL] [Abstract][Full Text] [Related]
12. Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
Vasudevan NT; Mohan ML; Gupta MK; Martelli EE; Hussain AK; Qin Y; Chandrasekharan UM; Young D; Feldman AM; Sen S; Dorn GW; Dicorleto PE; Naga Prasad SV
Circulation; 2013 Jul; 128(4):377-87. PubMed ID: 23785004
[TBL] [Abstract][Full Text] [Related]
13. Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.
Rengo G; Galasso G; Femminella GD; Parisi V; Zincarelli C; Pagano G; De Lucia C; Cannavo A; Liccardo D; Marciano C; Vigorito C; Giallauria F; Ferrara N; Furgi G; Filardi PP; Koch WJ; Leosco D
Eur J Prev Cardiol; 2014 Jan; 21(1):4-11. PubMed ID: 23689525
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
Schumacher SM; Gao E; Zhu W; Chen X; Chuprun JK; Feldman AM; Tesmer JJ; Koch WJ
Sci Transl Med; 2015 Mar; 7(277):277ra31. PubMed ID: 25739765
[TBL] [Abstract][Full Text] [Related]
15. G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart.
Pfleger J; Gross P; Johnson J; Carter RL; Gao E; Tilley DG; Houser SR; Koch WJ
J Mol Cell Cardiol; 2018 Oct; 123():108-117. PubMed ID: 30171848
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor kinases in normal and failing myocardium.
Huang ZM; Gold JI; Koch WJ
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3047-60. PubMed ID: 21622221
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.
Hata JA; Williams ML; Schroder JN; Lima B; Keys JR; Blaxall BC; Petrofski JA; Jakoi A; Milano CA; Koch WJ
J Card Fail; 2006 Jun; 12(5):360-8. PubMed ID: 16762799
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
[TBL] [Abstract][Full Text] [Related]
20. Novel roles for G protein-coupled receptor kinases in cardiac injury and repair.
Kayki-Mutlu G; Koch WJ
Biochem Soc Trans; 2023 Apr; 51(2):715-724. PubMed ID: 37013982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
